Topics

Latest "National Academy Sciences approves expel harassers" News Stories - Page: 20

08:02 EST 12th December 2019 | BioPortfolio

Here are the most relevant search results for "National Academy Sciences approves expel harassers" found in our extensive news archives from over 250 global news sources.

More Information about National Academy Sciences approves expel harassers on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about National Academy Sciences approves expel harassers for you to read. Along with our medical data and news we also list National Academy Sciences approves expel harassers Clinical Trials, which are updated daily. BioPortfolio also has a large database of National Academy Sciences approves expel harassers Companies for you to search.

Showing "National Academy Sciences approves expel harassers" News Articles 476–500 of 11,000+

Tuesday 3rd December 2019

Andrew Cohen Appointed as Clarify Medical’s Vice President of Marketing

Clarify Medical today announced the appointment of Andrew Cohen as its Vice President of Marketing, effective immediately. Mr. Cohen has more than 18 years of U.S. and international marketing experience in the life sciences, medical device, and clinical diagnostics industries. Throughout his career, he has held senior commercial positions at Advanced BioHealing Inc., Nuo Therapeutics, Millennium ...


Herbalife Nutrition Names Rhonda Vetere Chief Information Officer

Premier global nutrition company Herbalife Nutrition (NYSE:HLF), announced Rhonda Vetere has joined the Company as executive vice president and chief information officer, with global responsibility including information technology strategy and implementation. Bringing more than 25 years of experience as a global technology executive in the health, financial, insurance, and consumer packaged goo...

Evotec beteiligt sich an Finanzierungsrunde von Celmatix

FRANKFURT (Dow Jones)--Die im Bereich Wirkstoffforschung und -entwicklung tätige Evotec hat sich im Zuge einer Finanzierungsrunde gemeinsam mit Investoren wie Life Sciences Innovation Fund und Top...


Brii Biosciences Expands Therapeutic Focus to Include Neurosciences with Addition of John Kraus, M.D., Ph.D.

- Dr. Kraus to lead newly-created Neurosciences Therapy Area - Zhijian Chen, Ph.D., named Strategic Scientific Advisor Brii Biosciences, a clinical-stage company committed to serving patients’ needs and improving public health in China and around the world, today announced two leadership appointments that will guide the company’s expansion into neurosciences as a second therapeutic focus a...

Curt Medeiros, President of OPTUM Advanced Data and Analytics at UnitedHealth Group, Joins Catasys as President and Chief Operating Officer

Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Mr. Curt Medeiros as President and Chief Operating Officer. Mr. Terren Peizer, Chairman and CEO of Catasys, stated, “Catasys is evolving from being the leading healthcare engagement company at the intersection of behaviorial

Cresco Labs Inc. Establishes At-the-Market Offering

Cresco Labs Inc. ("Cresco Labs" or the "Company") (CSE:CL) (OTCQX:CRLBF) (FSE:6CQ), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it has entered into an equity distribution agreement (the "Equity Distribution Agreement") with Canaccord Genuity Corp. pursuant to which the Company may, from time to time, sell up to C$55 million of ...

SymphonyCare’s Empower Patient Portal Achieves 2015 Edition ONC Health IT Certification

SymphonyCare, the leading provider of integrated clinical and claims data solutions, today announced its EmpowerTM patient portal version 6.4 achieved certification from the 2015 Edition Office of the National Coordinator for Health

Celmatix Expands Strategic Partnership with Evotec in Women’s Health

PARTNERSHIP BUILDS ON THE EXISTING EVOTEC-CELMATIX ALLIANCE IN WOMEN’S HEALTH CELMATIX LEVERAGING PROPRIETARY MULTI-OMICS DATA PLATFORM FOR THERAPEUTIC DRUG DEVELOPMENT EVOTEC INVESTS IN A FINANCING ROUND ALONGSIDE INVESTORS INCLUDING LIFE SCIENCES INNOVATION FUND AND TOPSPIN FUND Celmatix Inc., the leading precision health company advancing the fields of reproductive medicine and fertil...

World Cancer Institute: OncoVacx / CancerVX, an OncoEpigenomic Immunotherapy Provides Medically Verifiable Reversal of Tumor Progression in 10 Cancer Types and Also Targets Treatment Resistant Malignancies Within the Nucleus of Cancer DNA.

Latest 2018 / 2019 Case Study reveals clinically effective reversal of Anal Cancer in 73 year old male with history of stroke, but achieving medically confirmed absence of disease progression and no recurrence of Anal Cancer for 22 months while maintaining weekly outpatient OncoEpigenomic DNA treatment Nathan Sassover, CEO of World Cancer Institute Inc. today stated: "We are seeing the extended ...

Brazil approves medical marijuana, as Latin America drug taboo softens

Brazil has approved medicinal cannabis-based products, the country's pharmaceutical regulator Anvisa said on Tuesday, becoming the latest drug-ravaged Latin American nation to sign off on medical marijuana.

Absolute Antibody Partners with the Recombinant Antibody Network to Facilitate Access to Engineered Recombinant Antibodies

200+ Recombinant Antibodies to be Engineered into New Formats to Advance Research. REDCAR, United Kingdom (PRWEB) December 03, 2019 Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Recombinant Antibody Network (RAN), a consortium of three expert centers at the University of Chicago, University of Toronto, an...

Veggie Eating Boosted by Tasty Names

Source: National Institutes of Health - Related MedlinePlus Pages: Nutrition

China's National Reimbursement Drug List to include Tyvyt by 2020

Innovent and Eli Lilly became the first partnership to gain a foothold into the National Reimbursement Drug List of China for -More- 

Aurinia to Present Preclinical Voclosporin Data at 2020 Keystone Symposia Conference

- Voclosporin demonstrated fewer adverse effects on beta cell function as compared to tacrolimus in preclinical model of diabetes - - Data supports differentiation of voclosporin versus legacy CNIs and potential best-in-class attributes - - Data to be presented at the Keystone Symposia Conference on Islet Cell Biology - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (“Aurinia” or...

Harnessing the power of CRISPR in space and time

Researchers in Vienna from Ulrich Elling’s laboratory at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – in collaboration with the Vienna BioCenter Core Facilities have developed a revolutionary CRISPR technology called “CRISPR-Switch”, which enables unprecedented c...

China approves Genetron's NGS system

China's National Medical Products Association has granted approval to Genetron Health's Genetron S5 clinical next-generation  -More- 

Could machine learning and AI help develop a better battery?

Scientists at Argonne National Laboratory are working on hurdling this stumbling block to medical device miniaturization.  -More- 

LeafLink Names MariMed’s Betty's Eddies™ as National Category Leader

Betty's Eddies™ Occupies Best Selling Slot in LeafLink ListMariMed Expands National Footprint and Brings New Products to New MarketsInfused Cannabis Products Occupy Increased Share of a Growing National Market NORWOOD, Mass., Dec. 03, 2019 (GLOBE NEWSWIRE) Read more...

FDA approves Cumberland’s methotrexate products line

The US Food and Drug Administration (FDA) has approved Cumberland Pharmaceuticals’ methotrexate products to treat adult and paediatric patients with...Read More... The post FDA approves Cumberland’s methotrexate products line appeared first on Pharmaceutical Technology.

Evotec Expands Strategic Partnership With Celmatix In Women's Health

PARTNERSHIP BUILDS ON THE EXISTING EVOTEC-CELMATIX-ALLIANCE IN WOMEN'S HEALTH CELMATIX LEVERAGING PROPRIETARY MULTI-OMICS DATA PLATFORM FOR THERAPEUTIC DRUG DEVELOPMENT EVOTEC INVESTS IN A FINANCING ROUND ALONGSIDE INVESTORS INCLUDING LIFE SCIENCES INNOVATION FUND AND TOPSPIN FUND HAMBURG, GERMANY / ACCESSWIRE / December 3, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, IS...

American Psychiatric Nurses Association Announces New Executive Director

The American Psychiatric Nurses Association (APNA) Board of Directors is thrilled to welcome Lisa Deffenbaugh Nguyen, MS, CAE as its new Executive Director. FALLS CHURCH, Va. (PRWEB) December 03, 2019 Lisa Deffenbaugh Nguyen, MS, CAE has more than a decade of experience in association management, is a Certified Association Executive, and possesses a keen understanding of APNA’s mission and purp...

Wes Wheeler Appointed to Lead UPS Healthcare and Life Sciences Unit

ATLANTA, Dec. 03, 2019 (GLOBE NEWSWIRE) Read more...

QBiotics Announces First Patient Dosed in its Phase I/II Clinical Trial of Tigilanol Tiglate for Head and Neck Cancer

First patient successfully dosed in QBiotics' Phase I/II clinical trial of tigilanol tiglate in patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Tigilanol tiglate is a novel, small molecule that is being tested as a single injection treatment for solid tumours The Phase I/II clinical trial is a dose escalation study in HNSCC patients designed to determine optimal dosage, safety...

China Adds 70 Drugs to Insurance Reimbursement List; Negotiates 61% Average Price Cuts

China's National Healthcare Security Administration announced that 70 drug have been added to the list of drugs eligible for insurance reimbursement after biopharmas agreed to price cuts that averaged 61%. Two new products from western companies, anemia treatment roxadustat from AstraZeneca and lung cancer therapy alecensa from Roche, are now covered by China's insurance plan. And China's domestic...

Carbios Receives € 1.4m From ADEME Following the Success of the First Milestone of Its CE-PET Research Project

Regulatory News: CARBIOS (Euronext Growth Paris: ALCRB) (Paris:ALCRB), a company pioneering new bio-industrial solutions to reinvent the lifecycle of plastic and textile polymers, announced the confirmed success of a key stage of the CE-PET1 project and as a result, that it has received a total amount of 1.4 million euros2 from the Investments for the Future Program (PIA) operated by ADEME (Fra...


Quick Search

News Quicklinks